Home
Portfolio
News
Contact
CG Oncology Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
CG Oncology
related
news
ADARx Pharmaceuticals raises 4.463 million in upsized US IPO
Reuters
September 25 2026
NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy
NASDAQ
July 14 2026
Get In Touch
Contact Us